Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 10Recruiting 5Active not recruiting 3Withdrawn 2Unknown 1Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Cognitive Dysfunction 2Breast Neoplasms 2Depression 1Breast Cancer Survivors 1

Interventions

pembrolizumab 439Carboplatin 322Nivolumab 298Cyclophosphamide 286Specimen Handling 271Magnetic Resonance Spectroscopy 259Cisplatin 250Paclitaxel 249Radiotherapy 230Dexamethasone 184Biopsy 182Gemcitabine 180durvalumab 171atezolizumab 152Doxorubicin 141Rituximab 138Lenalidomide 136Ipilimumab 134Docetaxel 132Bevacizumab 132Radiation 121Capecitabine 120Oxaliplatin 116Etoposide 116Radiosurgery 113Fluorouracil 112Pemetrexed 109fludarabine 106venetoclax 102Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Transcranial Direct Current Stimulation × Clear all
NCT02726763 2026-04-27

Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training

Memorial Sloan Kettering Cancer Center

Phase NA Active not recruiting
18 enrolled
Breast

Breast Cancer Survivors

NCT07083518 2025-07-24

Transcranial Direct Current Stimulation for Cancer-related Cognitive Impairment in Breast Cancer Survivors

Anhui Medical University

Phase NA Active not recruiting
60 enrolled
Breast

Breast Neoplasms, Cognitive Dysfunction

NCT06053775 2025-07-20

ONCODEP

University of Santiago de Compostela

Phase NA Active not recruiting
82 enrolled
Breast

Breast Neoplasms, Depression, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡